Prescience Partners up 70% in 2011, Shorting Chinese Frauds


Prescience Partners LP (the “Fund”) was up +1.36% after all fees in the month of December. In the year ended December 31, 2011, the Fund is up +68.93%.

Since inception in August 2009, the Fund is up +76.77% after all fees. An investment of $100,000 in the Fund at inception has grown to ~$176,770.


Canyon Capital Has Tapped Into The Pandemic Fallout: In-Depth Analysis [Q4 Letter]

CanyonCanyon Balanced Funds was up more than 41% net since the end of last year's first quarter. It took about 10 months for the fund to recover from the lows in that quarter, a few months longer than the 2009 rebound after the Global Financial Crisis. The fund has a little over $26 million in Read More

In 2011, we identified a compelling set of investment opportunities which proved very rewarding for our investors. At the same time, we played an active role in protecting public shareholders and defending the integrity of US financial markets.

Specifically, we exposed several fraudulent public companies that appeared to be hoodwinking other investors. To date, two of five of these companies have been halted from trading by the NASDAQ Listings Investigations Unit (see ABAT and APWR; the corresponding research exposés can be downloaded here and here) following the publication of our reports. In addition, the Securities and Exchange Commission opened a detailed investigation into APWR to determine whether it or any of its personnel violated the federal securities laws.

Looking forward we remain focused on equities at the smaller end of the spectrum of publicly traded companies, where we have identified several attractive opportunities in undervalued equities ripe for investor activism and where we continue to implement our event-driven short strategy.

Based on the breadth of our pipeline of well-researched ideas, we believe that today will also prove to have been a very attractive time to invest in the Fund. Our strategy is longer-term in nature; if you have a long-term orientation and are an accredited investor interested in learning more about our investment offering, please contact us.

Full December report below:

Prescience Investor Update 12 2011

No posts to display